Class Actions
PowerSchool Student Data Breach Litigation: MDL 3149 Status
What the PowerSchool student data breach litigation shows: the December 2024 incident, MDL No. 3149 and what the court record leaves undecided.
Archive
Blog
Every published article on Collective Claim, newest first: litigation records, regulatory actions and legal guides, each tied to dated primary sources.
66 articles · newest first
Last updated
This archive lists every article we have published, newest first, across all topics. Each entry is dated, and every article states what a court, agency or filing has actually done, with links to the primary documents.
Use the topic pages in the header for a narrower view, or the search box for a specific drug, device, chemical, statute or company.
How the archive is organised
- Topic hubs group articles by the kind of claim: mass tort, pharmaceutical, product liability, medical devices, environmental, personal injury and class actions.
- Legal guides explain the procedure behind the cases rather than a specific dispute.
- Articles are dated by publication and re-dated only when a substantive change is made; corrections are logged on the corrections policy page.
Class Actions
23andMe Data Breach Litigation: MDL 3098 and How It Ended
The 23andMe genetic data breach lawsuits were consolidated in MDL No. 3098 and resolved through a bankruptcy settlement. Here is what the record shows.
Mass Tort
McKinsey Opioid Consulting Litigation: MDL 2996 Explained
McKinsey faced suits over its opioid consulting, a $650 million federal resolution, and three class settlements. What the court record establishes.
Class Actions
AT&T Customer Data Breach Litigation: MDL 3114 Status
What the AT&T customer data breach litigation shows: the federal MDL in Texas, the March 2024 incident, and what the court record leaves undecided.
Mass Tort
NCAA Concussion Settlement: What the Monitoring Program Provides
The NCAA concussion settlement in MDL 2492 funds a 50-year medical monitoring program, not damages. What the court orders establish, and what they leave open.
Product Liability
Kia and Hyundai Theft Claims: MDL 3052 Status
Federal Kia and Hyundai theft claims are consolidated as MDL 3052. A $145 million class settlement is approved but on appeal, and insurer claims continue.
Product Liability
Juul Litigation: MDL 2913 Status and the Class Settlements
Federal Juul claims are consolidated as MDL 2913. Two approved class settlements total over $300 million, ten actions remain pending, and the FDA now authorizes some Juul products.
Product Liability
Ford DPS6 PowerShift Litigation: MDL 2814 Status and Rulings
Ford DPS6 transmission claims are consolidated as MDL 2814. The record shows warranty rulings, no transmission recall, and a trial set for December 2026.
Product Liability
Onewheel Litigation: MDL 3087 Status and Recall Record
Federal Onewheel claims are consolidated as MDL 3087. The record shows two CPSC recalls and a December 2025 settlement in principle, with no approval yet.
Pharmaceutical Lawsuits
Valsartan, Losartan and Irbesartan Recalls: What MDL 2875 Shows
A factual review of the sartan recalls and the federal litigation: the impurities found, the FDA actions, and what MDL 2875 has and has not decided.
Medical Device Litigation
Stryker LFIT V40 Hip Litigation: MDL 2768 Status
Federal claims about Stryker LFIT V40 femoral heads are consolidated as MDL 2768. The 2016 recall, the alleged taper failure and the docket's decline.
Pharmaceutical Lawsuits
GLP-1 NAION Lawsuits: What MDL 3163 Shows
A factual review of the federal GLP-1 eye-injury litigation: MDL 3163, the NAION claims, the EMA review and what US labels say.